Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06229366 |
| Title | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer (ACCEL) |
| Acronym | ACCEL |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Juravinski | Hamilton | L8V 5C2 | Canada | Details | ||
| Jewish General Hospital | Montreal | H3T 1E2 | Canada | Details | ||
| McGill University | Montreal | H4A 3J1 | Canada | Details | ||
| Centre Hospitalier Universite de QUEBEC | Québec | G1J 1Z4 | Canada | Details | ||
| Hopital De Chicoutimi | Saguenay | G7H 5H6 | Canada | Details | ||
| Princess Margaret Cancer Centre | Toronto | M5G 2M9 | Canada | Details | ||
| BC Cancer Vancouver | Vancouver | V5Z4E6 | Canada | Details |